Issue 1/2017
Content (20 Articles)
Enhancing Oral Absorption of β-Lapachone: Progress Till Date
Marival Bermejo, Victor Mangas-Sanjuan, Isabel Gonzalez-Alvarez, Marta Gonzalez-Alvarez
Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects
Ricardo Jorge Dinis-Oliveira
External Validation of a Recently Developed Population Pharmacokinetic Model for Hydromorphone During Postoperative Pain Therapy
Harald Ihmsen, Doris Rohde, Jürgen Schüttler, Christian Jeleazcov
Effect of Lactobacillus casei on the Pharmacokinetics of Amiodarone in Male Wistar Rats
Zuzana Matuskova, Pavel Anzenbacher, Rostislav Vecera, Michal Siller, Helena Tlaskalova-Hogenova, Jan Strojil, Eva Anzenbacherova
Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study
Yani Liu, Jianhong Wu, Zhongfang Li, Ying Luo, Fandian Zeng, Shaojun Shi
Pharmacokinetic Studies of Oxathio-Heterocycle Fused Chalcones
Krystyna Okoniewska, Marek T. Konieczny, Krzysztof Lemke, Tomasz Grabowski
Ocular Drug Distribution After Topical Administration: Population Pharmacokinetic Model in Rabbits
Nassim Djebli, Sonia Khier, Florence Griguer, Anne-Laure Coutant, Alexandra Tavernier, Gerard Fabre, Caroline Leriche, David Fabre
Pharmacokinetic Time Course Scaling of a Subcutaneously Administered Pegylated Peptide Conjugate for a First-in-Human Investigation
Elliot Offman, Andrea N. Edginton
Population Pharmacokinetics Modeling of Inhaled Umeclidinium for Adult Patients with Asthma
Shuying Yang, Laurie Lee, Steven Pascoe
Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein
Hanhua Zhang, Guangkui Ya, Hongbing Rui
Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel
Dorota Danielak, Marta Karaźniewicz-Łada, Karolina Wiśniewska, Piotr Bergus, Paweł Burchardt, Anna Komosa, Franciszek Główka
Pharmacokinetics, Safety and Tolerability of Sacubitril/Valsartan (LCZ696) After Single-Dose Administration in Healthy Chinese Subjects
Yi Han, Surya Ayalasomayajula, Wei Pan, Fan Yang, Yaozong Yuan, Thomas Langenickel, Markus Hinder, Sampath Kalluri, Parasar Pal, Gangadhar Sunkara
Identification of Transporters Involved in Beraprost Sodium Transport In Vitro
Keiyu Oshida, Masahiro Shimamura, Kazuhiro Seya, Akihiro Ando, Yohei Miyamoto
Absolute Bioavailability of Ponesimod, a Selective S1P1 Receptor Modulator, in Healthy Male Subjects
Margaux Boehler, Pierre-Eric Juif, Matthias Hoch, Jasper Dingemanse
Pharmacokinetics of Saquinavir Mesylate from Oral Self-Emulsifying Lipid-Based Delivery Systems
Thiago Caon, Jadel Muller Kratz, Gislaine Kuminek, Melina Heller, Gustavo Amadeu Micke, Bibiana Verlindo de Araujo, Letícia Scherer Koester, Cláudia Maria Oliveira Simões
Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling
Todd J. Zurlinden, Brad Reisfeld
Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy
Katharina Karsch, Xi Chen, Oliver Miera, Björn Peters, Patrick Obermeier, Roland C. Francis, Válerie Amann, Susanne Duwe, Pieter Fraaij, Alla Heider, Marcel de Zwart, Felix Berger, Albert Osterhaus, Brunhilde Schweiger, Barbara Rath
Stereoselective Conversion of Ketoprofen in Men Versus Women from Two Different Oral Dosage Formulations: Observations and Introspection of the Pharmacokinetic Data
Ranjeet Prasad Dash, Nuggehally R. Srinivas
Influence of Sex and Food on the Bioavailability and the R-to-S Conversion of Ketoprofen Stereoisomers in Humans
Pietro Fagiolino, Nikoletta Fotaki, Marta Vázquez
Erratum to: Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy
Yunli Yu, Quanying Zhang, Wenjun Xu, Chengzhe Lv, Gang Hao